Fulcrum Therapeutics, Inc.
FULC
$6.69
$0.172.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 214.11M | 226.60M | 241.02M | 257.23M | 273.78M |
| Total Receivables | 1.33M | 2.54M | 3.34M | 5.23M | 3.53M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.93M | 3.41M | 5.56M | 5.03M | 2.97M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 219.37M | 232.56M | 249.92M | 267.49M | 280.29M |
|
|
|||||
| Total Current Assets | 219.37M | 232.56M | 249.92M | 267.49M | 280.29M |
| Net Property, Plant & Equipment | 8.25M | 8.88M | 9.58M | 10.24M | 10.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.22M | 1.21M | 1.21M | 1.28M | 3.21M |
| Total Assets | 228.84M | 242.65M | 260.72M | 279.01M | 294.26M |
|
|
|||||
| Total Accounts Payable | 1.75M | 1.51M | 1.16M | 4.04M | 3.58M |
| Total Accrued Expenses | 4.77M | 3.91M | 7.23M | 7.93M | 6.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.29M | 2.24M | 2.19M | 2.13M | 2.08M |
| Total Finance Division Other Current Liabilities | 173.00K | 441.00K | 463.00K | 400.00K | 306.00K |
| Total Other Current Liabilities | 173.00K | 441.00K | 463.00K | 400.00K | 306.00K |
| Total Current Liabilities | 8.99M | 8.10M | 11.04M | 14.51M | 12.70M |
|
|
|||||
| Total Current Liabilities | 8.99M | 8.10M | 11.04M | 14.51M | 12.70M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.28M | 5.87M | 6.44M | 7.01M | 7.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 197.00K | 197.00K | 197.00K | 197.00K | 197.00K |
| Total Liabilities | 14.46M | 14.16M | 17.68M | 21.72M | 20.47M |
|
|
|||||
| Common Stock & APIC | 768.65M | 765.47M | 762.30M | 759.74M | 755.29M |
| Retained Earnings | -554.35M | -537.05M | -519.40M | -502.83M | -481.13M |
| Treasury Stock & Other | 82.00K | 70.00K | 130.00K | 379.00K | -366.00K |
| Total Common Equity | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 214.38M | 228.49M | 243.03M | 257.29M | 273.79M |
|
|
|||||